ARS Wealth Advisors Group
CVS icon

ARS Wealth Advisors Group’s CVS Health CVS Stock Holding History

ARS Wealth Advisors Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$699K Buy
8,158
+108
+1% +$10.6K 0.05% 113
2026
Q2 		$833K Buy
8,050
+225
+3% +$20.1K 0.07% 104
2026
Q1 		$562K Sell
7,825
-222
-3% -$17.1K 0.05% 120
2025
Q4 		$639K Buy
8,047
+459
+6% +$36.2K 0.06% 100
2025
Q3 		$572K Sell
7,588
-83
-1% -$5.69K 0.06% 102
2025
Q2 		$529K Buy
7,671
+81
+1% +$5.31K 0.06% 102
2025
Q1 		$514K Sell
7,590
-807
-10% -$48.3K 0.07% 91
2024
Q4 		$377K Sell
8,397
-50
-0.6% -$2.8K 0.05% 101
2024
Q3 		$531K Sell
8,447
-473
-5% -$27.6K 0.07% 99
2024
Q2 		$527K Sell
8,920
-16,178
-64% -$1.01M 0.07% 96
2024
Q1 		$2M Sell
25,098
-23,577
-48% -$1.8M 0.27% 50
2023
Q4 		$3.84M Sell
48,675
-74,556
-61% -$5.31M 0.57% 42
2023
Q3 		$8.6M Buy
123,231
+4,089
+3% +$290K 1.41% 27
2023
Q2 		$8.24M Buy
119,142
+5,069
+4% +$361K 1.31% 30
2023
Q1 		$8.48M Buy
114,073
+4,014
+4% +$337K 1.56% 27
2022
Q4 		$10.3M Sell
110,059
-7,440
-6% -$718K 1.69% 22
2022
Q3 		$11.2M Buy
117,499
+2,621
+2% +$259K 1.71% 17
2022
Q2 		$10.6M Buy
114,878
+729
+0.6% +$71.1K 1.46% 20
2022
Q1 		$11.6M Sell
114,149
-1,402
-1% -$147K 2.01% 19
2021
Q4 		$11.9M Buy
115,551
+726
+0.6% +$67.1K 2% 16
2021
Q3 		$9.7M Buy
+114,825
New +$9.6M 1.77% 19

Other funds holding CVS

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Canoe Financial
Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

ARS Wealth Advisors Group's CVS Position: Q3 2026 in Review

ARS Wealth Advisors Group increased its CVS Health (CVS) stake by 1.3% in Q3 2026, buying an estimated $10.6K and bringing the position to 8,158 shares worth $699K. The position accounts for 0.05% of the portfolio, ranked #113.

ARS Wealth Advisors Group first reported a position in CVS in Q3 2021 and has held it in 21 quarters since. The position peaked at $11.9M in Q4 2021. 1,001 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • ARS Wealth Advisors Group held 8,158 shares of CVS Health worth $699K as of Q3 2026.
  • ARS Wealth Advisors Group bought 108 CVS Health shares in Q3 2026, an estimated $10.6K.
  • CVS Health made up 0.05% of ARS Wealth Advisors Group's portfolio in Q3 2026, its #113 holding.
  • ARS Wealth Advisors Group first reported a position in CVS Health in Q3 2021 and has held it in 21 quarters since.
  • ARS Wealth Advisors Group's CVS Health position peaked at $11.9M in Q4 2021.
  • 1,001 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on ARS Wealth Advisors Group's 13F filing for Q3 2026, filed 16 Oct 2026.